Koers Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Aandelen
UNVO
IL0010935588
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 0,82 3,13 0,77 | Omzet 2020 | 33,68 128,02 31,39 | Marktkapitalisatie | 75,1 mln. 285 mln. 69,99 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -11 mln. -41,81 mln. -10,25 mln. | Nettowinst (verlies) 2020 | - 0 0 | EV/omzet 2019 | 35.543.010 x |
Nettoliquiditeiten 2019 | 22,82 mln. 86,74 mln. 21,27 mln. | Nettoschuld 2020 | 4,12 mln. 15,66 mln. 3,84 mln. | EV/omzet 2020 | 2.352.105 x |
K/w-verhouding 2019 * |
-
| K/w-verhouding 2020 |
-
| Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 59,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 47 | 04-04-93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 15-07-19 |
Golan Bitton
CEO | Chief Executive Officer | 47 | 04-04-93 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+46,79% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |